Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain

Biochemical and Biophysical Research Communications

Volumn 344, Issue 2, 2006, Pages 640-646

  Nilsson, Tatjana ^a   Bogdanovic, Nenad ^a   Volkman, Inga ^a   Winblad, Bengt ^a   Folkesson, Ronnie ^a   Benedikz, Eirikur ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Immunohistochemistry; Ornithine decarboxylase

Indexed keywords

ORNITHINE DECARBOXYLASE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN NUCLEUS; BRAIN REGION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PURKINJE CELL; STAINING;

AGED; ALZHEIMER DISEASE; BRAIN; HUMANS; ORNITHINE DECARBOXYLASE; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION;

EID: 33646475580     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.191     Document Type: Article

References (34)

1. Selkoe D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8 (1998) 447-453
2. Price D.L., and Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21 (1998) 479-505
3. Cao X., and Südhof T.C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
4. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., and Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110 (2002) 55-67
5. Nilsson T., Malkiewicz K., Gabrielsson M., Folkesson R., Winblad B., and Benedikz E. Antibody-bound amyloid precursor protein upregulates ornithine decarboxylase expression. Biochem. Biophys. Res. Commun. 341 (2006) 1294-1299
6. Schipper R.G., and Verhofstad A.A. Distribution patterns of ornithine decarboxylase in cells and tissues: facts, problems, and postulates. J. Histochem. Cytochem. 50 (2002) 1143-1160
7. Marton L.J., and Pegg A.E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 55-91
8. Johnson T.D. Modulation of channel function by polyamines. Trends Pharmacol. Sci. 17 (1996) 22-27
9. Kauppinen R.A., and Alhonen L.I. Transgenic animals as models in the study of the neurobiological role of polyamines. Progr. Neurobiol. 47 (1995) 545-553
10. Johnson T.D. Polyamines and cerebral ischemia. Prog. Drug Res. 50 (1998) 193-258
11. Bernstein H.G., and Müller M. The cellular localization of the l-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems. Progr. Neurobiol. 57 (1999) 485-505
12. Seiler N. Oxidation of polyamines and brain injury. Neurochem. Res. 25 (2000) 471-490
13. Frölich L., Blum-Degen D., Bernstein H.G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Türk A., Hoyer S., Zöchling R., Boissl K.W., Jellinger K., and Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural. Transm. 105 (1998) 423-438
14. Khan A.U., Di Mascio P., Medeiros M.H., and Wilson T. Spermine and spermidine protection of plasmid DNA against single-strand breaks induced by singlet oxygen. Proc. Natl. Acad. Sci. USA 89 (1992) 11428-11430
15. Ha H.C., Sirisoma N.S., Kuppusamy P., Zweier J.L., Woster P.M., and Casero Jr. R.A. The natural polyamine spermine functions directly as a free radical scavenger. Proc. Natl. Acad. Sci. USA 95 (1998) 11140-11145
16. Lukkarinen J.A., Gröhn O.H., Alhonen L.I., Jänne J., and Kauppinen R.A. Enhanced ornithine decarboxylase activity is associated with attenuated rate of damage evolution and reduction of infarct volume in transient middle cerebral artery occlusion in the rat. Brain Res. 826 (1999) 325-329
17. Lukkarinen J.A., Kauppinen R.A., Gröhn O.H., Oja J.M., Sinervirta R., Jarvinen A., Alhonen L.I., and Jänne J. Neuroprotective role of ornithine decarboxylase activation in transient focal cerebral ischaemia: a study using ornithine decarboxylase-overexpressing transgenic rats. Eur. J. Neurosci. 10 (1998) 2046-2055
18. Reeben M., Arbatova J., Palgi J., Miettinen R., Halmekytö M., Alhonen L., Jänne J., Riekkinen Sr. P., and Saarma M. Induced expression of neurotrophins in transgenic mice overexpressing ornithine decarboxylase and overproducing putrescine. J. Neurosci. Res. 45 (1996) 542-548
19. Bernstein H.G., and Müller M. Increased immunostaining for l-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients. Neurosci. Lett. 186 (1995) 123-126
20. Morrison L.D., Cao X.C., and Kish S.J. Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J. Neurochem. 71 (1998) 288-294
21. Yatin S.M., Yatin M., Aulick T., Ain K.B., and Butterfield D.A. Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci. Lett. 263 (1999) 17-20
22. Bogdanovic N., and Morris J.H. Diagnostic criteria for Alzheimer's disease in multicentre brain banking. In: Cruz-Sanches F.F., Ravid R., and Cuzner M.L. (Eds). Neuropathological Diagnostic Criteria for Brain Banking (1995), IOS Press, Amsterdam 20-29
23. Gundersen H.J. Stereology of arbitrary particles: a review of unbiased number and size estimators and a presentation of some new ones, in memory of William Thompson. J. Microsc. 143 (1986) 3-45
24. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
25. M.B.A. Berry, G. Wilken, V.H. Perry, Structure and function of neurons and glia in the central nervous system, in: Greenfield's Neuropathology, seventh ed., 2002, pp. 75-121.
26. Dawson T.P., Neal J.W., Llewellyn L., and Thomas C. Neuropathology Techniques (2003), Oxford University Press, Oxford pp. 162-179
27. D. Ellison, S. Love, Pathologic reactions in the CNS: structural abnormalities of axons, in: Neuropathology, 1998, pp. 1-18.
28. Chen Y., Liu W., McPhie D.L., Hassinger L., and Neve R.L. APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J. Cell Biol. 163 (2003) 27-33
29. Bussiere T., Giannakopoulos P., Bouras C., Perl D.P., Morrison J.H., and Hof P.R. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J. Comp. Neurol. 463 (2003) 281-302
30. Bussiere T., Gold G., Kovari E., Giannakopoulos P., Bouras C., Perl D.P., Morrison J.H., and Hof P.R. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience 117 (2003) 577-592
31. Keinanen R., Miettinen S., Yrjanheikki J., and Koistinaho J. Induction of ornithine decarboxylase mRNA in transient focal cerebral ischemia in the rat. Neurosci. Lett. 239 (1997) 69-72
32. Isomaa V.V., Pajunen A.E., Bardin C.W., and Janne O.A. Ornithine decarboxylase in mouse kidney: purification, characterization, and radioimmunological determination of the enzyme protein. J. Biol. Chem. 258 (1983) 6735-6740
33. Laitinen S.I., Laitinen P.H., and Pajunen A.E. The effect of testosterone on the half-life of ornithine decarboxylase-mRNA in mouse kidney. Biochem. Int. 9 (1984) 45-50
34. Gilad G.M., and Gilad V.H. Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain. Exp. Neurol. 111 (1991) 349-355